Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: UM1 AI148684
NCATS NIH HHS
Grant: UL1 TR002378
NIAID NIH HHS
Grant: UM1 AI148450
NIAID NIH HHS
Grant: UM1 AI148576
NCI NIH HHS
Grant: 75N91019D00024
NIAID NIH HHS
Grant: 75N93021C00012
NCI NIH HHS
Grant: 75N91022C00007
NIAID NIH HHS
Grant: UM1 AI148574
Department of Health and Human Services
National Cancer Institute
National Institutes of Health
FWCI
4.04
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals